Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

argenx SE (ARGX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
291.32-9.08 (-3.02%)
At close: 04:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close300.40
Open296.34
Bid291.05 x 1000
Ask393.00 x 900
Day's Range290.52 - 298.96
52 Week Range248.21 - 382.15
Volume150,984
Avg. Volume177,614
Market Cap15.081B
Beta (5Y Monthly)0.76
PE Ratio (TTM)N/A
EPS (TTM)-14.04
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est347.13
  • GlobeNewswire

    argenx to Present at Upcoming Investor Conferences

    November 10, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in several upcoming conferences: Guggenheim Healthcare Talks | Idea Forum | 3rd Annual Neuro/Immunology Day. Fireside chat on Monday, November 15, 2021 at 9:40 a.m. ET.Evercore ISI 4th Annual HealthCONx Conference. Fireside chat on Tuesday

  • GlobeNewswire

    argenx Reports Third Quarter 2021 Financial Results and Provides Business Update

    – U.S. and Japan commercial teams fully staffed ahead of potential launches of efgartigimod in generalized myasthenia gravis (gMG) – – Signed partnership agreement with Medison for distribution of efgartigimod in Israel – – Wim Parys, M.D. to retire as Chief Medical Officer in March 2022 – – Management to host conference call today at 2:30 pm CEST (8:30 am ET) – October 28, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives

  • GlobeNewswire

    argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021

    October 21, 2021Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that it will host a conference call and audio webcast on Thursday, October 28, 2021 at 2:30 pm CET (8:30 am ET) to discuss its third quarter 2021 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website

Advertisement
Advertisement